Primary Site >> Pancreatic Cancer
Gene >> PIK3CA
| 1. | |||||||||||
| Journal: | Oncogene. 1999 Sep 2;18(35):4891-8. | ||||||||||
| Title: | Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. | ||||||||||
| Author: | Mitsuuchi, Y|Johnson, S W|Sonoda, G|Tanno, S|Golemis, E A|Testa, J R | ||||||||||
| PMID: | 10490823 | ||||||||||
| 2. | |||||||||||
| Journal: | Clin Cancer Res. 2005 Apr 15;11(8):2875-8. | ||||||||||
| Title: | Frequent mutation of the PIK3CA gene in ovarian and breast cancers. | ||||||||||
| Author: | Levine, Douglas A|Bogomolniy, Faina|Yee, Cindy J|Lash, Alex|Barakat, Richard R|Borgen, Patrick I|Boyd, Jeff | ||||||||||
| PMID: | 15837735 | ||||||||||
| 3. | |||||||||||
| Journal: | Clin Cancer Res. 2006 Jun 15;12(12):3851-5. | ||||||||||
| Title: | PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas. | ||||||||||
| Author: | Schonleben, Frank|Qiu, Wanglong|Ciau, Nancy T|Ho, Daniel J|Li, Xiaojun|Allendorf, John D|Remotti, Helen E|Su, Gloria H | ||||||||||
| PMID: | 16778113 | ||||||||||
| 4. | |||||||||||
| Journal: | Hum Mutat. 2008 Feb;29(2):284-8. | ||||||||||
| Title: | PIK3CA cancer mutations display gender and tissue specificity patterns. | ||||||||||
| Author: | Benvenuti, Silvia|Frattini, Milo|Arena, Sabrina|Zanon, Carlo|Cappelletti, Vera|Coradini, Danila|Daidone, Maria Grazia|Pilotti, Silvana|Pierotti, Marco A|Bardelli, Alberto | ||||||||||
| PMID: | 18022911 | ||||||||||
| 5. | |||||||||||
| Journal: | Langenbecks Arch Surg. 2008 May;393(3):289-96. | ||||||||||
| Title: | PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas. | ||||||||||
| Author: | Schonleben, Frank|Qiu, Wanglong|Remotti, Helen E|Hohenberger, Werner|Su, Gloria H | ||||||||||
| PMID: | 18343945 | ||||||||||
| 6. | |||||||||||
| Journal: | Cancer Res. 2008 Apr 15;68(8):2841-9. | ||||||||||
| Title: | Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. | ||||||||||
| Author: | Jimeno, Antonio|Tan, Aik Choon|Coffa, Jordy|Rajeshkumar, N V|Kulesza, Peter|Rubio-Viqueira, Belen|Wheelhouse, Jenna|Diosdado, Begona|Messersmith, Wells A|Iacobuzio-Donahue, Christine|Maitra, Anirban|Varella-Garcia, Marileila|Hirsch, Fred R|Meijer, Gerrit | ||||||||||
| PMID: | 18413752 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncogene. 2008 Sep 18;27(42):5648-50. | ||||||||||
| Title: | AKT1(E17K) in human solid tumours. | ||||||||||
| Author: | Bleeker, F E|Felicioni, L|Buttitta, F|Lamba, S|Cardone, L|Rodolfo, M|Scarpa, A|Leenstra, S|Frattini, M|Barbareschi, M|Grammastro, M Del|Sciarrotta, M G|Zanon, C|Marchetti, A|Bardelli, A | ||||||||||
| PMID: | 18504432 | ||||||||||
| 8. | |||||||||||
| Journal: | PLoS One. 2009 Oct 14;4(10):e7464. | ||||||||||
| Title: | Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. | ||||||||||
| Author: | Soh, Junichi|Okumura, Naoki|Lockwood, William W|Yamamoto, Hiromasa|Shigematsu, Hisayuki|Zhang, Wei|Chari, Raj|Shames, David S|Tang, Ximing|MacAulay, Calum|Varella-Garcia, Marileila|Vooder, Tonu|Wistuba, Ignacio I|Lam, Stephen|Brekken, Rolf|Toyooka, Shinic | ||||||||||
| PMID: | 19826477 | ||||||||||
| 9. | |||||||||||
| Journal: | Clin Cancer Res. 2010 Oct 15;16(20):4928-37. | ||||||||||
| Title: | Key role of phosphoinositide 3-kinase class IB in pancreatic cancer. | ||||||||||
| Author: | Edling, Charlotte E|Selvaggi, Federico|Buus, Richard|Maffucci, Tania|Di Sebastiano, Pierluigi|Friess, Helmut|Innocenti, Paolo|Kocher, Hemant M|Falasca, Marco | ||||||||||
| PMID: | 20876794 | ||||||||||
| 10. | |||||||||||
| Journal: | Biol Pharm Bull. 2010;33(8):1261-7. | ||||||||||
| Title: | Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells. | ||||||||||
| Author: | Gong, Xiao-Guang|Lv, Yun-Fu|Li, Xin-Qiu|Xu, Fu-Guo|Ma, Qing-Yong | ||||||||||
| PMID: | 20686216 | ||||||||||
| 11. | |||||||||||
| Journal: | Am J Surg Pathol. 2011 Dec;35(12):1812-7. | ||||||||||
| Title: | Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. | ||||||||||
| Author: | Yamaguchi, Hiroshi|Kuboki, Yuko|Hatori, Takashi|Yamamoto, Masakazu|Shiratori, Keiko|Kawamura, Shunji|Kobayashi, Makio|Shimizu, Michio|Ban, Shinichi|Koyama, Isamu|Higashi, Morihiro|Shin, Nobuhiro|Ishida, Kazuyuki|Morikawa, Takanori|Motoi, Fuyuhiko|Unno, Mi | ||||||||||
| PMID: | 21945955 | ||||||||||
| 12. | |||||||||||
| Journal: | Mol Cancer Ther. 2011 Dec;10(12):2426-36. | ||||||||||
| Title: | GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway. | ||||||||||
| Author: | Wallin, Jeffrey J|Edgar, Kyle A|Guan, Jane|Berry, Megan|Prior, Wei Wei|Lee, Leslie|Lesnick, John D|Lewis, Cristina|Nonomiya, Jim|Pang, Jodie|Salphati, Laurent|Olivero, Alan G|Sutherlin, Daniel P|O'Brien, Carol|Spoerke, Jill M|Patel, Sonal|Lensun, Letitia| | ||||||||||
| PMID: | 21998291 | ||||||||||
| 13. | |||||||||||
| Journal: | J Gastroenterol. 2012 Feb;47(2):203-13. | ||||||||||
| Title: | Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. | ||||||||||
| Author: | Mohri, Dai|Asaoka, Yoshinari|Ijichi, Hideaki|Miyabayashi, Koji|Kudo, Yotaro|Seto, Motoko|Ohta, Miki|Tada, Motohisa|Tanaka, Yasuo|Ikenoue, Tsuneo|Tateishi, Keisuke|Isayama, Hiroyuki|Kanai, Fumihiko|Fukushima, Noriyoshi|Tada, Minoru|Kawabe, Takao|Omata, Mas | ||||||||||
| PMID: | 22041919 | ||||||||||
| 14. | |||||||||||
| Journal: | Cancer Med. 2012 Oct;1(2):207-17. | ||||||||||
| Title: | Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer. | ||||||||||
| Author: | Arcaroli, John|Quackenbush, Kevin|Dasari, Arvind|Powell, Rebecca|McManus, Martine|Tan, Aik-Choon|Foster, Nathan R|Picus, Joel|Wright, John|Nallapareddy, Sujatha|Erlichman, Charles|Hidalgo, Manuel|Messersmith, Wells A | ||||||||||
| PMID: | 23342270 | ||||||||||
| 15. | |||||||||||
| Journal: | Clin J Gastroenterol. 2012 Dec;5(6):413-20. | ||||||||||
| Title: | Intraductal tubulopapillary neoplasm of the pancreas with somatic BRAF mutation. | ||||||||||
| Author: | Urata, Takahiro|Naito, Yoshiki|Nagamine, Michiko|Izumi, Yoshihiro|Tonaki, Ginga|Iwasaki, Hajime|Sasaki, Akiko|Yamasaki, Akira|Minami, Nobuhiro|Yoshioka, Rituko|Kitada, Hideki|Takekuma, Yoshi|Yokomizo, Hiroshi|Fukuda, Seiji|Yamaguchi, Hiroshi|Kuboki, Yuko| | ||||||||||
| PMID: | 26181322 | ||||||||||
| 16. | |||||||||||
| Journal: | Oncotarget. 2013 Feb;4(2):277-88. | ||||||||||
| Title: | Efemp1 and p27(Kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models. | ||||||||||
| Author: | Diersch, Sandra|Wenzel, Patrick|Szameitat, Melanie|Eser, Philipp|Paul, Mariel C|Seidler, Barbara|Eser, Stefan|Messer, Marlena|Reichert, Maximilian|Pagel, Philipp|Esposito, Irene|Schmid, Roland M|Saur, Dieter|Schneider, Gunter | ||||||||||
| PMID: | 23470560 | ||||||||||
| 17. | |||||||||||
| Journal: | Clin Cancer Res. 2013 Dec 15;19(24):6830-41. | ||||||||||
| Title: | Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas. | ||||||||||
| Author: | Garcia-Carracedo, Dario|Turk, Andrew T|Fine, Stuart A|Akhavan, Nathan|Tweel, Benjamin C|Parsons, Ramon|Chabot, John A|Allendorf, John D|Genkinger, Jeanine M|Remotti, Helen E|Su, Gloria H | ||||||||||
| PMID: | 24132918 | ||||||||||
| 18. | |||||||||||
| Journal: | Cancer Cytopathol. 2013 Dec;121(12):688-94. | ||||||||||
| Title: | Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms. | ||||||||||
| Author: | Young, Geneva|Wang, Kai|He, Jie|Otto, Geoff|Hawryluk, Matthew|Zwirco, Zac|Brennan, Tina|Nahas, Michelle|Donahue, Amy|Yelensky, Roman|Lipson, Doron|Sheehan, Christine E|Boguniewicz, Ann B|Stephens, Philip J|Miller, Vincent A|Ross, Jeffrey S | ||||||||||
| PMID: | 23893923 | ||||||||||
| 19. | |||||||||||
| Journal: | Mol Cancer Ther. 2013 Jun;12(6):853-64. | ||||||||||
| Title: | Bcl-2/Bcl-xL inhibition increases the efficacy of MEK inhibition alone and in combination with PI3 kinase inhibition in lung and pancreatic tumor models. | ||||||||||
| Author: | Tan, Nguyen|Wong, Maureen|Nannini, Michelle A|Hong, Rebecca|Lee, Leslie B|Price, Stephen|Williams, Karen|Savy, Pierre Pascal|Yue, Peng|Sampath, Deepak|Settleman, Jeffrey|Fairbrother, Wayne J|Belmont, Lisa D | ||||||||||
| PMID: | 23475955 | ||||||||||
| 20. | |||||||||||
| Journal: | J Gastrointest Oncol. 2013 Mar;4(1):20-9. | ||||||||||
| Title: | Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma. | ||||||||||
| Author: | Weiss, Guy A|Rossi, Michael R|Khushalani, Nikhil I|Lo, Ken|Gibbs, John F|Bharthuar, Anubha|Cowell, John K|Iyer, Renuka | ||||||||||
| PMID: | 23450128 | ||||||||||
| 21. | |||||||||||
| Journal: | Diagn Pathol. 2014 Jan 20;9:11. | ||||||||||
| Title: | Case report: Intraductal tubulopapillary neoplasm of the pancreas with unique clear cell phenotype. | ||||||||||
| Author: | Ahls, Maria Gabriele|Niedergethmann, Marco|Dinter, Dietmar|Sauer, Christian|Luttges, Jutta|Post, Stefan|Marx, Alexander|Gaiser, Timo | ||||||||||
| PMID: | 24443801 | ||||||||||
| 22. | |||||||||||
| Journal: | Pancreas. 2014 Mar;43(2):245-9. | ||||||||||
| Title: | PIK3CA mutations in mucinous cystic neoplasms of the pancreas. | ||||||||||
| Author: | Garcia-Carracedo, Dario|Chen, Zong-Ming|Qiu, Wanglong|Huang, Alicia S|Tang, Sophia M|Hruban, Ralph H|Su, Gloria H | ||||||||||
| PMID: | 24518503 | ||||||||||
| 23. | |||||||||||
| Journal: | BMC Cancer. 2014 May 25;14:370. | ||||||||||
| Title: | Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway. | ||||||||||
| Author: | Shi, Pengfei|Yin, Tao|Zhou, Feng|Cui, Pengfei|Gou, Shanmiao|Wang, Chunyou | ||||||||||
| PMID: | 24885711 | ||||||||||
| 24. | |||||||||||
| Journal: | Mol Ther. 2014 Dec;22(12):2056-68. | ||||||||||
| Title: | Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapies. | ||||||||||
| Author: | Ranzani, Marco|Annunziato, Stefano|Calabria, Andrea|Brasca, Stefano|Benedicenti, Fabrizio|Gallina, Pierangela|Naldini, Luigi|Montini, Eugenio | ||||||||||
| PMID: | 25195596 | ||||||||||
| 25. | |||||||||||
| Journal: | Gastroenterology. 2014 Dec;147(6):1405-16.e7. | ||||||||||
| Title: | PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice. | ||||||||||
| Author: | Wu, Chia-Yen C|Carpenter, Eileen S|Takeuchi, Kenneth K|Halbrook, Christopher J|Peverley, Louise V|Bien, Harold|Hall, Jason C|DelGiorno, Kathleen E|Pal, Debjani|Song, Yan|Shi, Chanjuan|Lin, Richard Z|Crawford, Howard C | ||||||||||
| PMID: | 25311989 | ||||||||||
| 26. | |||||||||||
| Journal: | Front Physiol. 2014 Oct 15;5:391. | ||||||||||
| Title: | Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts. | ||||||||||
| Author: | Falasca, Marco|Maffucci, Tania | ||||||||||
| PMID: | 25360116 | ||||||||||
| 27. | |||||||||||
| Journal: | Oncotarget. 2015 Mar 10;6(7):4553-61. | ||||||||||
| Title: | Molecular landscape of pancreatic cancer: implications for current clinical trials. | ||||||||||
| Author: | Heestand, Gregory M|Kurzrock, Razelle | ||||||||||
| PMID: | 25714017 | ||||||||||
| 28. | |||||||||||
| Journal: | Transl Oncogenomics. 2015 Nov 23;7(Suppl 1):13-31. | ||||||||||
| Title: | c-Met as a Target for Personalized Therapy. | ||||||||||
| Author: | Garajova, Ingrid|Giovannetti, Elisa|Biasco, Guido|Peters, Godefridus J | ||||||||||
| PMID: | 26628860 | ||||||||||
| 29. | |||||||||||
| Journal: | Pathol Res Pract. 2015 Dec;211(12):1034-9. | ||||||||||
| Title: | A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm? | ||||||||||
| Author: | Muraki, Takashi|Uehara, Takeshi|Sano, Kenji|Oota, Hiroyoshi|Yoshizawa, Akihiko|Asaka, Shiho|Tateishi, Ayako|Otsuki, Toshiaki|Shingu, Kunihiko|Matoba, Hisanori|Kobayashi, Shota|Ichimata, Shojiro|Watanabe, Takayuki|Itou, Tetsuya|Tanaka, Eiji | ||||||||||
| PMID: | 26586167 | ||||||||||
| 30. | |||||||||||
| Journal: | Int J Clin Exp Pathol. 2015 Aug 1;8(8):9672-80. eCollection 2015. | ||||||||||
| Title: | Multifocal intraductal tubulopapillary neoplasm of the pancreas with total pancreatectomy: report of a case and review of literature. | ||||||||||
| Author: | Kolby, David|Thilen, Johan|Andersson, Roland|Sasor, Agata|Ansari, Daniel | ||||||||||
| PMID: | 26464736 | ||||||||||
| 31. | |||||||||||
| Journal: | Oncogenesis. 2015 Oct 5;4:e169. | ||||||||||
| Title: | PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors. | ||||||||||
| Author: | Payne, S N|Maher, M E|Tran, N H|Van De Hey, D R|Foley, T M|Yueh, A E|Leystra, A A|Pasch, C A|Jeffrey, J J|Clipson, L|Matkowskyj, K A|Deming, D A | ||||||||||
| PMID: | 26436951 | ||||||||||
| 32. | |||||||||||
| Journal: | Gastroenterology. 2015 Nov;149(6):1501-10. | ||||||||||
| Title: | A combination of molecular markers and clinical features improve the classification of pancreatic cysts. | ||||||||||
| Author: | Springer, Simeon|Wang, Yuxuan|Dal Molin, Marco|Masica, David L|Jiao, Yuchen|Kinde, Isaac|Blackford, Amanda|Raman, Siva P|Wolfgang, Christopher L|Tomita, Tyler|Niknafs, Noushin|Douville, Christopher|Ptak, Janine|Dobbyn, Lisa|Allen, Peter J|Klimstra, David | ||||||||||
| PMID: | 26253305 | ||||||||||
| 33. | |||||||||||
| Journal: | Ann Oncol. 2015 Sep;26(9):1923-9. | ||||||||||
| Title: | A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. | ||||||||||
| Author: | O'Neil, B H|Scott, A J|Ma, W W|Cohen, S J|Leichman, L|Aisner, D L|Menter, A R|Tejani, M A|Cho, J K|Granfortuna, J|Coveler, A L|Olowokure, O O|Baranda, J C|Cusnir, M|Phillip, P|Boles, J|Nazemzadeh, R|Rarick, M|Cohen, D J|Radford, J|Fehrenbacher, L|Bajaj, R | ||||||||||
| PMID: | 26091808 | ||||||||||
| 34. | |||||||||||
| Journal: | Oncotarget. 2015 Mar 30;6(9):7209-20. | ||||||||||
| Title: | Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. | ||||||||||
| Author: | Mitsuhashi, Kei|Nosho, Katsuhiko|Sukawa, Yasutaka|Matsunaga, Yasutaka|Ito, Miki|Kurihara, Hiroyoshi|Kanno, Shinichi|Igarashi, Hisayoshi|Naito, Takafumi|Adachi, Yasushi|Tachibana, Mami|Tanuma, Tokuma|Maguchi, Hiroyuki|Shinohara, Toshiya|Hasegawa, Tadashi|I | ||||||||||
| PMID: | 25797243 | ||||||||||
| 35. | |||||||||||
| Journal: | Nature. 2015 Feb 26;518(7540):495-501. | ||||||||||
| Title: | Whole genomes redefine the mutational landscape of pancreatic cancer. | ||||||||||
| Author: | Waddell, Nicola|Pajic, Marina|Patch, Ann-Marie|Chang, David K|Kassahn, Karin S|Bailey, Peter|Johns, Amber L|Miller, David|Nones, Katia|Quek, Kelly|Quinn, Michael C J|Robertson, Alan J|Fadlullah, Muhammad Z H|Bruxner, Tim J C|Christ, Angelika N|Harliwong, | ||||||||||
| PMID: | 25719666 | ||||||||||
| 36. | |||||||||||
| Journal: | Virchows Arch. 2015 Feb;466(2):237-41. | ||||||||||
| Title: | Basaloid carcinoma of the pancreas--clinicopathological presentation and oncogenetic snapshot of a rare entity. | ||||||||||
| Author: | Szasz, A Marcell|Szirtes, Ildiko|Tihanyi, Balazs|Barkaszi, Bernadett|Baranyai, Zsolt|Tihanyi, Tibor|Harsanyi, Laszlo|Timar, Jozsef|Kulka, Janina | ||||||||||
| PMID: | 25432630 | ||||||||||
| 37. | |||||||||||
| Journal: | Oncotarget. 2015 Mar 10;6(7):4553-61. | ||||||||||
| Title: | Molecular landscape of pancreatic cancer: implications for current clinical trials. | ||||||||||
| Author: | Heestand, Gregory M|Kurzrock, Razelle | ||||||||||
| PMID: | 11051691 | ||||||||||
| 38. | |||||||||||
| Journal: | Cancer Genet. 2015 Sep;208(9):441-7. | ||||||||||
| Title: | Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach. | ||||||||||
| Author: | Hagemann, Ian S|O'Neill, Patrick K|Erill, Ivan|Pfeifer, John D | ||||||||||
| PMID: | 26227479 | ||||||||||
| 39. | |||||||||||
| Journal: | Oncotarget. 2016 Nov 15;7(46):74797-74806. | ||||||||||
| Title: | Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression. | ||||||||||
| Author: | Durante, Sandra|Vecchiarelli, Silvia|Astolfi, Annalisa|Grassi, Elisa|Casadei, Riccardo|Santini, Donatella|Panzacchi, Riccardo|Ricci, Claudio|Serravalle, Salvatore|Tarantino, Giuseppe|Falconi, Mirella|Teti, Gabriella|Indio, Valentina|Pession, Andrea|Minni, | ||||||||||
| PMID: | 27566563 | ||||||||||
| 40. | |||||||||||
| Journal: | Genet Mol Res. 2016 Jul 29;15(3). pii: gmr6991. | ||||||||||
| Title: | Abnormal expression of PTEN and PIK3CA in pemetrexed-resistant human pancreatic cancer cell line Patu8988. | ||||||||||
| Author: | Shi, X|Gu, H T|Lin, S B|Zhang, Y|Yang, J|Qian, C J | ||||||||||
| PMID: | 27525871 | ||||||||||
| 41. | |||||||||||
| Journal: | Bull Cancer. 2016 Jul-Aug;103(7-8):643-50. | ||||||||||
| Title: | [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "a la carte" treatment?]. | ||||||||||
| Author: | Dreyer, Chantal|Afchain, Pauline|Trouilloud, Isabelle|Andre, Thierry | ||||||||||
| PMID: | 27345450 | ||||||||||
| 42. | |||||||||||
| Journal: | Clin Cancer Res. 2016 Dec 1;22(23):5805-5817. | ||||||||||
| Title: | Therapeutic Benefit of Selective Inhibition of p110alpha PI3-Kinase in Pancreatic Neuroendocrine Tumors. | ||||||||||
| Author: | Soler, Adriana|Figueiredo, Ana M|Castel, Pau|Martin, Laura|Monelli, Erika|Angulo-Urarte, Ana|Mila-Guasch, Maria|Vinals, Francesc|Baselga, Jose|Casanovas, Oriol|Graupera, Mariona | ||||||||||
| PMID: | 27225693 | ||||||||||
| 43. | |||||||||||
| Journal: | Mol Cancer Ther. 2016 May;15(5):985-97. | ||||||||||
| Title: | Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling. | ||||||||||
| Author: | Puskas, Laszlo G|Man, Imola|Szebeni, Gabor|Tiszlavicz, Laszlo|Tsai, Susan|James, Michael A | ||||||||||
| PMID: | 26939707 | ||||||||||
| 44. | |||||||||||
| Journal: | Med Oncol. 2016 Apr;33(4):32. | ||||||||||
| Title: | KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review. | ||||||||||
| Author: | Zhou, Lei|Baba, Yoshifumi|Kitano, Yuki|Miyake, Keisuke|Zhang, Xiaobo|Yamamura, Kensuke|Kosumi, Keisuke|Kaida, Takayoshi|Arima, Kota|Taki, Katsunobu|Higashi, Takaaki|Imai, Katsunori|Hashimoto, Daisuke|Yamashita, Yoichi|Chikamoto, Akira|Beppu, Toru|Tan, Xia | ||||||||||
| PMID: | 26927447 | ||||||||||
| 45. | |||||||||||
| Journal: | Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):27-38. | ||||||||||
| Title: | RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies. | ||||||||||
| Author: | Fang, Bingliang | ||||||||||
| PMID: | 26350096 | ||||||||||
| 46. | |||||||||||
| Journal: | Cancer Lett. 2017 Jan 1;384:86-93. | ||||||||||
| Title: | Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications. | ||||||||||
| Author: | Yu, Chih-Chieh|Qiu, Wanglong|Juang, Caroline S|Mansukhani, Mahesh M|Halmos, Balazs|Su, Gloria H | ||||||||||
| PMID: | 27725226 | ||||||||||
| 47. | |||||||||||
| Journal: | J Gastrointest Oncol. 2017 Feb;8(1):164-172. | ||||||||||
| Title: | Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis. | ||||||||||
| Author: | Borazanci, Erkut|Millis, Sherri Z|Kimbrough, Jeffery|Doll, Nancy|Von Hoff, Daniel|Ramanathan, Ramesh K | ||||||||||
| PMID: | 28280620 | ||||||||||
| 48. | |||||||||||
| Journal: | Mol Cancer Res. 2017 Jul;15(7):929-941. | ||||||||||
| Title: | Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells. | ||||||||||
| Author: | Hao, Fang|Xu, Qinhong|Zhao, Yinglan|Stevens, Jan V|Young, Steven H|Sinnett-Smith, James|Rozengurt, Enrique | ||||||||||
| PMID: | 28360038 | ||||||||||
| 49. | |||||||||||
| Journal: | Cell Rep. 2017 Jul 25;20(4):999-1015. | ||||||||||
| Title: | A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution. | ||||||||||
| Author: | Anderson, Grace R|Winter, Peter S|Lin, Kevin H|Nussbaum, Daniel P|Cakir, Merve|Stein, Elizabeth M|Soderquist, Ryan S|Crawford, Lorin|Leeds, Jim C|Newcomb, Rachel|Stepp, Priya|Yip, Catherine|Wardell, Suzanne E|Tingley, Jennifer P|Ali, Moiez|Xu, Mengmeng|Ry | ||||||||||
| PMID: | 28746882 | ||||||||||
| 50. | |||||||||||
| Journal: | Oncol Rep. 2017 Dec;38(6):3567-3573. | ||||||||||
| Title: | MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma. | ||||||||||
| Author: | Chen, Qiuyang|Wang, Peng|Fu, Yue|Liu, Xinchun|Xu, Wenbin|Wei, Jishu|Gao, Wentao|Jiang, Kuirong|Wu, Junli|Miao, Yi | ||||||||||
| PMID: | 29039566 | ||||||||||
| 51. | |||||||||||
| Journal: | Oncotarget. 2017 Jun 28;8(55):93464-93475. | ||||||||||
| Title: | Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. | ||||||||||
| Author: | Gleeson, Ferga C|Voss, Jesse S|Kipp, Benjamin R|Kerr, Sarah E|Van Arnam, John S|Mills, John R|Marcou, Cherisse A|Schneider, Amber R|Tu, Zheng Jin|Henry, Michael R|Levy, Michael J | ||||||||||
| PMID: | 29212165 | ||||||||||
| 52. | |||||||||||
| Journal: | Oncogene. 2018 Feb 8;37(6):821-832. | ||||||||||
| Title: | RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1. | ||||||||||
| Author: | Chen, S-H|Gong, X|Zhang, Y|Van Horn, R D|Yin, T|Huber, L|Burke, T F|Manro, J|Iversen, P W|Wu, W|Bhagwat, S V|Beckmann, R P|Tiu, R V|Buchanan, S G|Peng, S-B | ||||||||||
| PMID: | 29059158 | ||||||||||
| 53. | |||||||||||
| Journal: | Arch Pathol Lab Med. 2018 Mar;142(3):420-423. | ||||||||||
| Title: | Intraductal Tubulopapillary Neoplasm of the Pancreas: An Overview. | ||||||||||
| Author: | Kim, Hyunsung|Ro, Jae Y | ||||||||||
| PMID: | 29494224 | ||||||||||
| 54. | |||||||||||
| Journal: | Clin Cancer Res. 2018 Sep 15;24(18):4444-4454. | ||||||||||
| Title: | Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance. | ||||||||||
| Author: | Wartenberg, Martin|Cibin, Silvia|Zlobec, Inti|Vassella, Erik|Eppenberger-Castori, Serenella|Terracciano, Luigi|Eichmann, Micha David|Worni, Mathias|Gloor, Beat|Perren, Aurel|Karamitopoulou, Eva | ||||||||||
| PMID: | 29661773 | ||||||||||
| 55. | |||||||||||
| Journal: | Exp Ther Med. 2018 Aug;16(2):1499-1504. | ||||||||||
| Title: | miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA. | ||||||||||
| Author: | Zhang, Shengping|Cai, Jiarong|Xie, Wenjun|Luo, Hui|Yang, Fei | ||||||||||
| PMID: | 30112070 | ||||||||||
| 56. | |||||||||||
| Journal: | Surg Case Rep. 2018 Aug 16;4(1):96. | ||||||||||
| Title: | Intrapancreatic recurrence of intraductal tubulopapillary neoplasm (ITPN) 16 years after the initial surgery for noninvasive ITPN: a case report. | ||||||||||
| Author: | Saeki, Kiyoshi|Miyasaka, Yoshihiro|Ohishi, Yoshihiro|Yamamoto, Takeo|Matsuda, Ryota|Mochidome, Naoki|Mori, Yasuhisa|Nakata, Kohei|Ohtsuka, Takao|Ishigami, Kousei|Minoda, Yosuke|Koga, Yutaka|Oda, Yoshinao|Nakamura, Masafumi | ||||||||||
| PMID: | 30116990 | ||||||||||